Hallandale Pharmacy semaglutide formulary: Flex-Dose vials
Hallandale Pharmacy publishes semaglutide Flex-Dose vials in four volume sizes — 1 mL, 2 mL, 3 mL, and 4 mL — all at 2.5 mg/mL, plus a Double-Strength Flex-Dose at 5 mg/mL in a 3 mL vial. The Flex-Dose format is designed so a single multi-dose vial can service multiple titration steps by adjusting the draw volume, which reduces SKU inventory but puts a premium on accurate SIG and draw instructions for each step. Concentrations and vial sizes should be confirmed directly with Hallandale, as their formulary can change.
As of 2026, FDA regulations require that compounded semaglutide — following the resolution of the national shortage in early 2025 — be prescribed for an individual patient with documented clinical justification, not as a routine alternative to the commercial product. Prescribers ordering through Hallandale or any 503A compounder need documentation on file. This regulatory context is the same across all compounders and is separate from any evaluation of Hallandale Pharmacy specifically.